Dr. John Kane discussed the RAISE trial for people with first episode psychosis

Professor David Nutt

Edmond J Safra Professor of Neuropsychopharmacology in the Division of Brain Sciences Imperial College London, UK.

View all of our content on Schizophrenia
Published 21.01.2018
Permissions
Published 21.01.2018
Permissions

Related content

description Article
Brain Insulin Action and Metabolic Dysregulation in Schizophrenia: From Mechanistic Insights to Novel Interventions

The complex interplay between metabolic dysfunction and brain insulin resistance in schizophrenia warrants further investigation as it represents a unique opportunity for both mechanistic inquiry and the development of novel therapeutic strategies that can improve metabolic and cognitive outcomes in this population.

24.10.2025 Schizophrenia
image Image
Central and peripheral causes of brain insulin resistance in schizophrenia

Central and peripheral causes of brain insulin resistance in schizophrenia

24.10.2025 Schizophrenia
image Image
Brain insulin action in relation to peripheral and central outcomes
24.10.2025 Schizophrenia